Jane Street’s ENDRA Life Sciences NDRA Stock Holding History

Jane Street’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-320	Closed	-$2.25K	–	10170
2024 Q3	$2.25K	Buy	320 +253	+378%	+$19.6K	﹤0.01%	9438
2024 Q2	$11.4K	Buy	67 +46	+219%	+$19.8K	﹤0.01%	9100
2024 Q1	$20.9K	Buy	+21	New	+$41.2K	﹤0.01%	8896
2018 Q4	–	Hold	0	–	-$36K	–	5446
2018 Q3	–	Hold	0	–	–	–	4949

Other funds holding NDRA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Jane Street's NDRA Position: Q4 2024 in Review

Jane Street sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 320 shares — an estimated $2.25K sold.

Jane Street first reported a position in NDRA in Q1 2024 and held it in 3 quarters. The position peaked at $20.9K in Q1 2024. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

Jane Street reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
Jane Street sold 320 ENDRA Life Sciences shares in Q4 2024, an estimated $2.25K.
Jane Street first reported a position in ENDRA Life Sciences in Q1 2024 and held it in 3 quarters.
Jane Street's ENDRA Life Sciences position peaked at $20.9K in Q1 2024.
4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.